EBS

Emergent Biosolutions Stock Analysis

AI Rating

Good
  • Quality5/10
  • Growth↑ 8/10
  • Momentum↑ 7/10
Emergent Biosolutions sales and earnings growth
EBS Growth
Good
  • Revenue Y/Y↓ -29.91%
  • EPS Y/Y↑ 136.13%
  • FCF Y/Y↓ -72.61%
Emergent Biosolutions gross and profit margin trends
EBS Profitability
Fair
  • Gross margin ↑ 54.50%
  • EPS margin↓ 9.60%
  • ROIC↓ 12.90%
Emergent Biosolutions net debt vs free cash flow
EBS Risk
Good
  • Debt / Equity↓ 1.1
  • Debt / FCF↑ 10.4
  • Interest coverage↓ 2.8

Emergent Biosolutions stock volatility is higher than the overall market. We give it a Good risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗